Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Increasing skeletal muscle mass and strength during incretin-based weight loss
Obesity pillars, 2026;19:100317
Is There a Better Day of the Week to Administer Semaglutide or Tirzepatide? A Systematic Literature Review
Medicina (Kaunas, Lithuania), 2026;62(8)
Anisotropic Electrostatics in the Instability of GLP‑1 Analog Micelles: Effects of Electrolytes, Denaturants, pH, and Temperature
ACS omega, 2026;11(33):49381-49401
Microdosing Tirzepatide in Multi-Dose Pens: Clinical Individualization, Safety, and Evidence Gaps
Obesity (Silver Spring, Md.), 2026
Glucagon-Like Peptide-1 Receptor Agonists and Related Incretin Therapies in Dermatology: Patient Selection and Shared Decision-Making
Clinics in dermatology, 2026
Trends in preoperative weight loss modalities among patients receiving body contouring surgery
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2026
Semaglutide attenuates a proteomics-based dementia risk signature in older adults with overweight or obesity and cardiovascular disease without diabetes: A post hoc analysis of the SELECT phase 3 trial
Alzheimer's & dementia (Amsterdam, Netherlands), 2026;18(3):e70432
Microfluidic-assisted formulation of hydrophobic ion pairing-Based solid lipid nanoparticles for semaglutide delivery
International journal of pharmaceutics, 2026;:127291
Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia
The Journal of international medical research, 2026;54(8):3000605261470651
Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis
Digestive diseases and sciences, 2026
Semaglutide Exposure During Pregnancy: Results from the FAERS Database
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications
International journal of molecular sciences, 2026;27(16)
Medication-overuse headache in migraine: could GLP-1 receptor agonists treat the addiction-like phenotype?
Expert opinion on pharmacotherapy, 2026
Retatrutide: Obesity drug opens to “compassionate use” in US after speculation Trump took it
BMJ (Clinical research ed.), 2026;394:e100530
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
The lancet. Diabetes & endocrinology, 2026
One-year weight loss and metabolic outcomes after laparoscopic sleeve gastrectomy in adolescents compared with young adults: A propensity score-matched cohort study
Obesity pillars, 2026;19:100315
Out-of-Pocket Costs and Adherence to Semaglutide for Obesity Among Commercially Insured Adults
JAMA health forum, 2026;7(8):e263113
Tirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report
Cureus, 2026;18(8):e114114
Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia
Drug and alcohol review;45(6):e70231
Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis
Journal of endocrinological investigation, 2026